TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | 4 | -4 | 17 | -38 | -53 | -12 |
| P | %wins | 50 | 100 | 0 | 100 | 0 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/22/13 14:48 | 11/21/13 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Uy George | CA | O | Chief Co | P | 25 | 8.36 | 1 | 3 | 2 | 184 | D | 49 | 49 | 64 | 8 | 3 | -13 | -8 | -5 | 3 | 7 | -1 | 24 | -38 | -53 |
11/20/13 17:44 | 11/19/13 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Uy George | CA | O | Chief Co | P | 17 | 8.61 | 0 | 2 | 1 | 181 | D | 250 | 59 | 75 | 15 | 12 | -8 | 0 | 0 | -4 | 0 | -7 | 10 | -38 | -52 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |